STEPHEN HAHN to Etanidazole
This is a "connection" page, showing publications STEPHEN HAHN has written about Etanidazole.
Connection Strength
0.617
-
Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients. Cancer Biother Radiopharm. 2012 Sep; 27(7):412-9.
Score: 0.111
-
Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma. Eur J Nucl Med Mol Imaging. 2010 Nov; 37(11):2048-59.
Score: 0.096
-
Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1024-31.
Score: 0.080
-
EF5 binding and clinical outcome in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2006 Mar 01; 64(3):922-7.
Score: 0.071
-
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients. Clin Cancer Res. 2004 Jul 15; 10(14):4630-8.
Score: 0.063
-
Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res. 2004 Mar 01; 64(5):1886-92.
Score: 0.062
-
Hypoxia in human intraperitoneal and extremity sarcomas. Int J Radiat Oncol Biol Phys. 2001 Feb 01; 49(2):587-96.
Score: 0.050
-
Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res. 2000 Apr 01; 60(7):2018-24.
Score: 0.047
-
Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors. Radiat Res. 2008 Dec; 170(6):677-90.
Score: 0.021
-
Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res. 2004 Dec 15; 10(24):8177-84.
Score: 0.016